UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
−Removed: The following table contains information with respect to purchases made by or on behalf of Equifax or any “affiliated purchaser” (as defined in Rule 10b-18(a) (3) under the Securities Exchange Act of 1934), of our common stock during our third quarter ended September 30, 2020:
+Added: The following table contains information with respect to purchases made by or on behalf of Equifax or any “affiliated purchaser” (as defined in Rule 10b-18(a) (3) under the Securities Exchange Act of 1934), of our common stock during our first quarter ended March 31, 2021:
of Shares Average
8 unchanged sentences
Period Purchased (1) Per Share (2) Plans or Programs Programs (3)
−Removed: July 1 - July 31, 2020 7,155 $ — — $ 590,092,166
−Removed: August 1 - August 31, 2020 2,660 $ — — $ 590,092,166
−Removed: September 1 - September 30, 2020 36,270 $ — — $ 590,092,166
+Added: January 1 - January 31, 2021 666 $ — — $ 590,092,166
+Added: February 1 - February 28, 2021 8,270 $ 164.10 13,333 $ 587,904,221
+Added: March 1 - March 31, 2021 41,234 $ 170.67 186,667 $ 556,045,764
Total 50,170 200,000
−Removed: (1) The total number of shares purchased for the quarter includes shares surrendered, or deemed surrendered, in satisfaction of the exercise price and/or to satisfy tax withholding obligations in connection with the exercise of
−Removed: employee stock options, totaling 7,155 shares for the month of July 2020, 2,660 shares for the month of August 2020, and 36,270 shares for the month of September 2020.
+Added: (1) The total number of shares purchased for the quarter includes shares surrendered, or deemed surrendered, in satisfaction of the exercise price and/or to satisfy tax withholding obligations in connection with the exercise of employee stock options, totaling 666 shares for the month of January 2021, 8,270 shares for the month of February 2021, and 41,234 shares for the month of March 2021.
(2) Average price paid per share for shares purchased as part of our share repurchase program (includes brokerage commissions).
−Removed: (3) At September 30, 2020, the amount authorized for future share repurchases under the share repurchase program was $590.1 million.
+Added: (3) At March 31, 2021, the amount authorized for future share repurchases under the share repurchase program was $556.0 million.
The program does not have a stated expiration date.
1 unchanged sentence
Our Revolver restricts our ability to pay cash dividends on our capital stock or repurchase capital stock if a default or event of default exists or would result if these payments were to occur, according to the terms of the applicable credit agreements.
+Added: 10.1* Form of Restricted Stock Unit Award Agreement (CEO) under the Equifax Inc.
+Added: Amended and Restated 2008 Omnibus Incentive Plan (for awards granted in or after February 2021).
+Added: 10.2* Form of Premium-Priced Stock Option Award Agreement (CEO) under the Equifax Inc.
+Added: Amended and Restated 2008 Omnibus Incentive Plan (for awards granted in or after February 2021).
+Added: 10.3* Form of Performance Share Award Agreement (TSR) (CEO) under the Equifax Inc.
+Added: Amended and Restated 2008 Omnibus Incentive Plan (for awards granted in or after February 2021).
+Added: 10.4* Form of Restricted Stock Unit Award Agreement (Senior Leadership Team) under the Equifax Inc.
+Added: Amended and Restated 2008 Omnibus Incentive Plan (for awards granted in or after February 2021).
+Added: 10.5* Form of Non-Qualified Stock Option Award Agreement (Senior Leadership Team) under the Equifax Inc.
+Added: Amended and Restated 2008 Omnibus Incentive Plan (for awards granted in or after February 2021).
+Added: 10.6* Form of Performance Share Award Agreement (TSR) (Senior Leadership Team) under the Equifax Inc.
+Added: Amended and Restated 2008 Omnibus Incentive Plan (for awards granted in or after February 2021).
+Added: 10.7 Letter Agreement, dated February 4, 2021, between the Company and Mark W.
+Added: Begor (incorporated by reference to Exhibit 10.1 to Equifax’s Form 8-K filed February 9, 2021).
31.1 Rule 13a-14(a) Certification of Chief Executive Officer
2 unchanged sentences
32.2 Section 1350 Certification of Chief Financial Officer
+Added: 101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
4 unchanged sentences
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
+Added: * Filed herewith
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: October 22, 2020 By:
+Added: April 22, 2021 By:
Chief Executive Officer
(Principal Executive Officer)
−Removed: October 22, 2020 /s/ John W.
+Added: April 22, 2021 /s/ John W.
Corporate Vice President and
1 unchanged sentence
(Principal Financial Officer)
−Removed: October 22, 2020 /s/ James M.
+Added: April 22, 2021 /s/ James M.
Chief Accounting Officer and Corporate Controller
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.